Correlation of measured and calculated serum osmolality during mannitol or hypertonic saline infusion in patients after craniotomy: a study protocol and statistical analysis plan for a randomised controlled trial

Qian Li, Ming Xu, Jian-Xin Zhou, Qian Li, Ming Xu, Jian-Xin Zhou

Abstract

Introduction: Brain oedema is a major complication after craniotomy. Hyperosmolar agents have been used as the medical treatment for this condition. Measurement and estimation of serum osmolality during hyperosmolar agent infusion is of clinical importance to evaluate clinical efficacy, adjust dosage and avoid side effects. However, several studies have shown that calculated serum osmolality may lead to a systematic bias compared with direct measurement. In the present study, mannitol or hypertonic saline (HS) will be used in patients after elective craniotomy. We aim to determine the accuracy of serum osmolality estimation during the application of hyperosmolar agent.

Methods and analysis: The study is a prospective, randomised, double-blinded, controlled, parallel-group design. Adult patients requiring the use of hyperosmolar agents for the prevention or treatment of postoperative brain oedema are enrolled and assigned randomly to one of the two treatment study groups, labelled as 'M group' and 'HS group'. Patients in the M and HS groups receive intravenous infusion of 125 mL of either 20% mannitol or 3.1% sodium chloride solution, respectively. Data will be collected immediately before the infusion of study agents, 15, 30, 60, 120, 240 and 360 min after the start of infusion of experimental agents, which includes serum osmolality, concentration of serum sodium, potassium, urea and glucose. Serum osmolality will be measured by means of freezing point depression. Estimated serum osmolality will also be calculated by using four formulas published previously. Osmole gap is calculated as the difference between the measured and the estimated values. The primary endpoint is the correlation of measured and estimated serum osmolality during hyperosmolar agent infusion.

Ethics and dissemination: The study was approved by the International Review Board (IRB) of Beijing Tiantan Hospital, Capital Medical University. Study findings will be disseminated through peer-reviewed publications and conference presentations.

Trial registration number: ClinicalTrials.gov identifier: NCT02037815.

Keywords: Neurosurgery.

References

    1. Bruder N, Ravussin P. Recovery from anesthesia and postoperative extubation of neurosurgical patients: a review. J Neurosurg Anesthesiol 1999;11:282–93
    1. Wong JM, Panchmatia JR, Ziewacz JE, et al. Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus 2012;33:E16.
    1. McLaughlin N, Bojanowski MW. Early surgery-related complications after aneurysm clip placement: an analysis of causes and patient outcomes. J Neurosurg 2004;101:600–6
    1. Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995;13:479–509
    1. Rabinstein AA. Treatment of cerebral edema. Neurologist 2006;12:59–73
    1. Rozet I, Tontisirin N, Muangman S, et al. Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance. Anesthesiology 2007;107:697–704
    1. Quentin C, Charbonneau S, Moumdjian R, et al. A comparison of two doses of mannitol on brain relaxation during supratentorial brain tumor craniotomy: a randomized trial. Anesth Analg 2013;116:862–8
    1. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004;1:219–33
    1. Ropper AH. Hyperosmolar therapy for raised intracranial pressure. N Engl J Med 2012;367:746–52
    1. Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care 2011;14:222–8
    1. Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011;39:554–9
    1. Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2012;116:210–21
    1. Lazaridis C, Neyens R, Bodle J, et al. High-osmolarity saline in neurocritical care: systematic review and meta-analysis. Crit Care Med 2013;41:1353–60
    1. Rickard AC, Smith JE, Newell P, et al. Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury. Emerg Med J. Published Online First: 28 June 2013. doi:
    1. Fink ME. Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline. Continuum (Minneap Minn) 2012;18:640–54
    1. Rottenberg DA, Hurwitz BJ, Posner JB. The effect of oral glycerol on intraventricular pressure in man. Neurology 1977;27:600–8
    1. Visweswaran P, Massin EK, Dubose TD., Jr Mannitol-induced acute renal failure. J Am Soc Nephrol 1997;8:1028–33
    1. Sweeney TE, Beuchat CA. Limitations of methods of osmometry: measuring the osmolality of biological fluids. Am J Physiol 1993;264:R469–80
    1. Fazekas AS, Funk GC, Klobassa DS, et al. Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med 2013;39:302–8
    1. Garcia-Morales EJ, Cariappa R, Parvin CA, et al. Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004;32:986–91
    1. Vialet R, Leone M, Albanese J, et al. Calculated serum osmolality can lead to a systematic bias compared to direct measurement. J Neurosurg Anesthesiol 2005;17:106–9
    1. Acikgoz S, Can M, Mungan AG, et al. Comparison of the calculated and measured osmolality in intracranial bleeding and head injury patients. J Emerg Med 2009;36:217–19
    1. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10

Source: PubMed

3
Tilaa